Stockscreener 앱 받기
3.4471
28.26%
0.7571
Nrx Pharmaceuticals Inc 주식(NRXP)의 최신 뉴스
HOPE Therapeutics Secures Major $27M Funding Deal, NRx Pharma Gains Strategic Investment - StockTitan
HOPE Therapeutics to Acquire Dura Medical, Expanding Mental Health Treatment Network in Florida - StockTitan
HOPE Therapeutics, Inc., an NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Subsidiary, Will Host an Investor Workshop for Qualified Institutional Investors at the Mar-A-Lago Club During the Week of January 6, 2025 - PR Newswire
HOPE Therapeutics Plans $100M Revenue Mental Health Clinic Acquisition Strategy at Mar-a-Lago Workshop - StockTitan
Acquisition of Kadima Neuropsychiatry Institute for CNS & - openPR
Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics - The Malaysian Reserve
NRx Pharma unit to acquire psychiatric facility Kadima - MSN
NRx Pharmaceuticals Stock Rises 33% on Psychiatry Clinic Acquisition - MarketWatch
NRx Pharmaceuticals Announces Agreement with LifeSci Associates to Provide Financial Services and Support - GuruFocus.com
NRx Pharma to buy Kadima psychiatric clinic (NRXP:NASDAQ) - Seeking Alpha
NRx Pharmaceuticals (NASDAQ:NRXP) Earns Buy Rating from D. Boral Capital - Defense World
Walt Disney Company (DIS-N) QuotePress Release - The Globe and Mail
Crowdstrike Holdings Inc (CRWD-Q) QuotePress Release - The Globe and Mail
New Drug Application to the FDA for the Treatment of Suicidal - openPR
NRx Pharmaceuticals Takes Bold Step Toward FDA Approval for NRX-100 in Treatment of Suicidal Depression - Tandav Media
Best Momentum Stocks to Buy for December 30th - Yahoo Finance
NRx Pharmaceuticals seeks FDA nod for suicidal depression drug - Investing.com India
NRx Pharmaceuticals seeks FDA nod for suicidal depression drug By Investing.com - Investing.com Nigeria
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression - StreetInsider.com
NRx Pharma Advances FDA Application for Groundbreaking Ketamine Depression Treatment - StockTitan
New Strong Buy Stocks for December 24th - MSN
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024 - The Eastern Progress Online
NRX Pharmaceuticals chairman Jonathan Javitt buys $46,800 in stock By Investing.com - Investing.com Canada
NRX Pharmaceuticals chairman Jonathan Javitt buys $46,800 in stock - Investing.com India
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic - Kilgore News Herald
Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics - The Eastern Progress Online
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024 - The Eastern Progress Online
Caterpillar Inc (CAT-N) QuotePress Release - The Globe and Mail
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024 - The Eastern Progress Online
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials" - The Eastern Progress Online
Ascendiant Capital Markets Issues Positive Forecast for NRx Pharmaceuticals (NASDAQ:NRXP) Stock Price - Defense World
NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on - GuruFocus.com
NRx Pharmaceuticals (NRXP) Upgraded to Buy: Here's Why - MSN
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter - GuruFocus.com
NRx Pharmaceuticals CEO to Present at NobleCon20 Emerging Growth Conference - StockTitan
NRx Pharmaceuticals reiterates shares target with Buy rating on Q3 report - Investing.com Nigeria
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper - GuruFocus.com
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Po - GuruFocus.com
Earnings call: NRx Pharmaceuticals projects profitability by 2025 - Investing.com Canada
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer - The Malaysian Reserve
NRX Pharmaceuticals Strengthens Leadership with New CFO Appointment - TipRanks
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2024 Earnings Call Transcript - Insider Monkey
NRx Pharmaceuticals Reports Progress in Drug Development - TipRanks
NRx Pharmaceuticals names Michael Abrams as new CFO - Investing.com
NRx Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
NRXPNRX Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
NRX Pharmaceuticals Inc (NRXP) Quarterly 10-Q Report - Quartzy
NRX Pharmaceuticals Advances in Mental Health Sector - TipRanks
3.20%
0.58%
자본화:
|
볼륨(24시간):